Physiological evidence suggests that this polymorphism affects blood lipid levels and insulin sensitivity, as the Ser allele carriers exhibit higher levels of insulin resistance and lipid dysregulation, which can lead to worse outcomes in patients already suffering from metabolic comorbidities [38,39]. Here, INS is linked to Insulin resistance.